Study Reveals Significant Increase in Insurer Prescription Denials

A recent JAMA study reports a 67% surge in first-time prescription rejections by insurance companies between 2018 and 2024. This trend creates substantial barriers to care, as nearly half of patients facing initial denials do not obtain alternative medications within three months. The findings underscore growing challenges in accessing essential treatments due to insurance practices.